EYPT
NASDAQ
$12.66
EyePoint Pharmaceuticals Inc (EYPT)
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $40.50 (+219.91%)
Market Cap
$1.16B
FCF 5Y CAGR
+82.17%
Free Cash Flow Yield
-23.49%
Beta (5Y)
1.24
Price Chart
Valuation
Market Cap$1.16B
Forward P/E6.16
P/S152.51
P/B5.00
Profitability
Total Revenue (TTM)$7.61M
Gross Profit (TTM)-$225M
EBITDA-$279M
Operating Margin-450.7%
EPS-$3.55
Financial Health
Free Cash Flow Yield-23.49%
Growth & Risk
EPS 5Y CAGR+6.42%
Revenue 5Y CAGR-25.98%
FCF 5Y CAGR+82.17%
Beta (5Y)1.24
Sharpe Ratio0.58